Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
1.
Registration Statement (Form S-3 No. 333-266720) of Janux Therapeutics, Inc.,
2.
Registration Statement (Form S-8 No. 333-257039) pertaining to the 2017 Equity Incentive Plan (Prior Plan), the 2021 Equity Incentive Plan, and the 2021 Employee Stock Purchase Plan of Janux Therapeutics, Inc., and
3.
Registration Statements (Form S-8 Nos. 333-263712 and 333-270470) pertaining to the 2021 Equity Incentive Plan, and the 2021 Employee Stock Purchase Plan of Janux Therapeutics, Inc.;
of our report dated March 8, 2024, with respect to the financial statements of Janux Therapeutics, Inc., included in this Annual Report (Form 10-K) for the year ended December 31, 2023.
/s/ Ernst & Young LLP
San Diego, California
March 8, 2024